Although it has been shown that TGF-β contributes to the induction of cell cycle arrest, accumulating data demonstrates that the resistance of cancer cells into TGF-β reverses its anti-tumor impact and this signaling pathway may enhance the progression of tumor cells [268–272]. Here, TGFB1 is linked to neoplasm.